Waning Immunity Most Consistent With Recent Mumps Outbreaks

TUESDAY, Jan. 10, 2023 (HealthDay News) -- A waning immunity model is most consistent with recently observed resurgent outbreaks of mumps in countries with high vaccine coverage, according to a study published online Jan. 9 in the Proceedings of the National Academy of Sciences.
Noting that multiple countries with high vaccine coverage have experienced resurgent outbreaks of mumps, Deven V. Gokhale, from the Odum School of Ecology at the University of Georgia in Athens, and colleagues proposed two putative mechanisms of vaccine failure as driving observed trends: gradual waning of immunity and the introduction of novel viral genotypes capable of evading vaccinal immunity. A statistical likelihood-based hypothesis testing was conducted using a mechanistic transmission model on age-structured epidemiological, demographic, and vaccine uptake time series data focusing on the United States.
The researchers found that the data were most consistent with the waning immunity model; by age 18 years, an estimated 32.8 percent of individuals had lost vaccine-derived immunity. The waning model reproduces features of the epidemiological data, including the shift in mumps incidence toward older individuals, recent recurrence of mumps outbreaks, and the high proportion of mumps cases among previously vaccinated individuals.
"We found that, due to the combination of waning immunity and primary vaccine failure, robust herd immunity cannot be achieved with the present vaccine and immunization schedule," the authors write. "Indeed, our results support, in principle, the administration of regular booster doses to achieve and maintain herd immunity."
Related Posts
AHA News: ¿Apasionado de los deportes? Veamos cómo el ver un partido de fútbol puede afectar su salud
MARTES, 18 de julio de 2023 (American Heart Association News) -- Crystal...
Only One in Five Parents Plan to Get COVID-19 Vaccine for Children Under 5 When Available
WEDNESDAY, May 4, 2022 (HealthDay News) -- Only 18 percent of parents of...
Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years
TUESDAY, Feb. 1, 2022 (HealthDay News) -- Pfizer Inc. plans to ask the U.S. Food...